Gilead Sciences is a biopharmaceutical company that discovers, develops, and commercializes innovative therapeutics in areas of unmet medical need. The company’s mission is to advance the care of patients suffering from life-threatening diseases worldwide.

Headquartered in Foster City, California, Gilead has operations in North America, Europe, Asia, and Australia. For more information, please visit Gilead.com.

We have an exciting opportunity within US Medical Affairs for a Director, Medical Affairs, Strategic Evidence Generation and Scientific Collaborations, Oncology. This role will be onsite in Foster City, CA., or Parsippany, NJ.

Reporting to the Senior Director and Lead of Strategic Evidence Generation and Scientific Collaborations US Medical Affairs (USMA), this role is a position responsible for co-developing the US Medical Affairs strategy for evidence generation across a portion of the solid tumor and hematologic programs.

The key functions of this role will be to represent and consider the healthcare environment of the US with internal and external stakeholders involved in cancer therapies across approved and pipeline molecules and indications, including the Global Medical Affairs team, US Patient Access and Quality team, Scientific Communications/Publications, Medical Affairs Outcomes Research, Commercial Strategy, Marketing, Value, and Market Access, Clinical Research/Development, US Public Affairs, US Government Affairs, Patient Engagement, Business Conduct (Legal), and the field-based US Medical Science Liaisons.